Brief: Jiangxi Rimag Says Hunan Rimag To Buy 100% Equity In Zhongya Diagnosis For RMB29.5 Million
09/06/2025 18:14
June 9 (Reuters) - Jiangxi Rimag Group Co Ltd 2522.HK: HUNAN RIMAG TO BUY 100% EQUITY IN ZHONGYA DIAGNOSIS FOR RMB29.5 MILLION Further company coverage: 2522.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on Jiangxi Rimag
See all newsBrief: Jiangxi Rimag Announces Transaction On Acquisition Of 100% Equity Interests In Target Cos
Brief: Jiangxi Rimag Says Each Of Co, Shanghai Ronggongshe To Provide Joint, Several Liability Guarantee
Brief: Jiangxi Rimag Group Repurchases 194,000 H Shares For HK$2 MLN
Brief: Jiangxi Rimag Says Chairman And CEO Chen Zhaoyang Purchases 55,000 H Shares
Brief: Jiangxi Rimag Group To Repurchase H Shares